Raynard L Bateman

Title: Raynard L Bateman: Innovator in Pharmaceutical Chemistry

Introduction

Raynard L Bateman is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrrolo pyrimidine derivatives. His research focuses on developing compounds that can serve as inhibitors for specific enzyme families, which can have profound implications for disease treatment.

Latest Patents

Bateman holds a patent for "1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof." This invention relates to pyrazolo pyrimidine derivatives that are useful as inhibitors of the short chain dehydrogenase/reductase (SDR) family of NAD(P)(H) dependent oxido-reductases. The patent further discusses pharmaceutical compositions and methods for preventing or treating diseases using these derivatives. Specifically, it highlights a 1H-Pyrrolo[2.3-d]pyrimidine compound, which can be a pharmaceutically acceptable salt or prodrug.

Career Highlights

Bateman's career is marked by his dedication to research and innovation in the pharmaceutical sector. He is affiliated with the University of California, where he continues to explore new avenues in drug development and therapeutic applications. His work has the potential to lead to significant advancements in medical treatments.

Collaborations

Some of Bateman's notable coworkers include Masahiro Tanaka and Chao Zhang. Their collaborative efforts contribute to the ongoing research and development in the field of pharmaceutical chemistry.

Conclusion

Raynard L Bateman is a distinguished inventor whose work on pyrrolo pyrimidine derivatives showcases his commitment to advancing pharmaceutical science. His contributions are paving the way for new therapeutic options in disease treatment.